90 cancer groups and centers urge CMS to rescind proposed lung cancer screening reimbursement cuts

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

90 CANCER GROUPS AND CANCER CENTERS, in a sign-on letter, urged the Center for Medicare & Medicaid Services to rescind proposed reimbursement cuts for lung cancer screening in its proposed rule on the 2017 Hospital Outpatient Prospective Payment System. The proposal lowers the reimbursement for low-dose CT lung cancer screenings by 44 percent, from $112.49...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

The California Institute for Regenerative Medicine, a state agency tasked with awarding billions of dollars of scientific funding for stem cell and gene therapy, has rescinded a controversial policy that was disrupting the flow of funding to cancer research.
NCI has emerged relatively unscathed in the president’s FY 2027 budget request that would slash $15.8 billion from HHS funding, cut NIH overall by about 10%, eliminate three NIH institutes and centers, and move the Institute for Environmental Health Sciences and its circa $1 billion budget out of NIH.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login